Mangoceuticals Announces the Official Launch of MangoRx Affiliate Marketing Program to Enhance and Accelerate Topline Growth

Mangoceuticals Announces the Official Launch of MangoRx Affiliate Marketing Program to Enhance and Accelerate Topline Growth

Mangoceuticals, Inc.Dallas, Texas, Oct. 12, 2023 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), an organization centered on growing, advertising and promoting a spread of males’s well being and wellness merchandise by way of a safe telemedicine platform, together with its uniquely formulated erectile dysfunction (ED) drug branded “Mango,” is happy to announce the official launch of its online marketing program by way of its newly designed web site at www.MangoIncome.com.“Affiliate advertising applications have been proven to drive big features in belief and consciousness when correctly marketed and executed accurately and we imagine that this technique will add further model recognition and notoriety for our MangoRx model,” remarked Jacob Cohen, CEO and Co-Founder of MangoRx. “As affiliate entrepreneurs are compensated based mostly on gross sales and efficiency, this new and dynamic channel is ideal for rising further topline revenues whereas at the identical time decreasing the upfront money burden that has historically been spent on digital advertising and promoting. We imagine {that a} well-executed and marketed online marketing program can lead to driving greater than roughly 20% of the Company’s general gross income.”According to a latest online marketing survey, the world online marketing business is value over $17 billion and is anticipated to develop to a market measurement of $27.78 billion by 2027. Additionally, 81% of manufacturers use affiliate applications to increase model consciousness and drive gross sales with these online marketing applications accounting for 16% of all web orders in the U.S. Major manufacturers get 5% to 25% of their general on-line gross sales from online marketing with 20% of model entrepreneurs claiming online marketing is their most profitable income driving channel.The Company has partnered with one of the prime advertising companies and software program suppliers in the online marketing business to guarantee all the constructing blocks are in place to supercharge its topline future development.Story continuesMangoRx has chosen Impact Radius (www.impression.com), an organization trusted by 1,000s of main world manufacturers equivalent to equivalent to Kohl’s, Best Buy, Uber, Microsoft, Target, Levi’s, Adidas, Yeti, and Gap, amongst others, as its premier affiliate automation and influencer administration platform. Impact Radius has labored with corporations offering cutting-edge backend software program administration for online marketing applications in addition to an actively managed recruiting database of greater than 7 million influencers enthusiastic about serving to rising manufacturers blossom and thrive. Impact Radius will even deal with the administration of toolkits for online marketing companions.Furthermore, MangoRx has partnered with Hamster Garage (www.hamstergarage.com), a partnerships and affiliate administration company to help MangoRx in constructing and managing its partnership applications. Hamster Garage has taken on over 40,000 online marketing accomplice relationships to assist partner-clients increase over $9.3 billion, with its common program driving 300% effectivity throughout the mission. Hamster Garage will drive affiliate discovery and curiosity, coordinating and managing affiliate relationships for MangoRx.Cohen added, “we’ve got full confidence that online marketing represents a brand new avenue for driving accelerated gross sales development for MangoRx and its stakeholders, which is our primary precedence. We imagine we’ve got a top-tier, premium product. Now we’ve got top-tier companions and a viable technique for massively augmenting our visibility and model worth. We look ahead to offering further updates on this program quickly.”To be taught extra about the perks and advantages of the MangoRx online marketing program, go to us at www.MangoIncome.com for extra data.About MangoCreated utilizing a particular formulation that includes both the identical lively ingredient as in Cialis™ (Tadalafil) or Viagra™ (Sildenafil), every half of the Mango formulation performs a crucial position in serving to males obtain optimum efficiency. We imagine the key to our success lies in our distinctive mix of components, that are utilized in U.S. Food and Drug Administration (“FDA”) authorized medication. Mango comprises a mix of both Sildenafil or Tadalafil together with Oxytocin and L-Arginine which were historically used to deal with sexual dysfunction.Mango is a prescription treatment that should be authorized by a doctor. After a person has accomplished an internet tele-health go to, our community of medical suppliers will evaluation and approve a prescription if medically acceptable. Mango is a quickly dissolved pill (RDT) that’s absorbed orally. For greatest outcomes, we advise taking Mango no less than quarter-hour earlier than partaking in sexual exercise. Sildenafil and Tadalafil, one of the essential components in Mango, sometimes have results that final up to 4 and 36 hours, respectively.About MangoceuticalsMangoceuticals, Inc. is an organization centered on growing, advertising, and promoting a spread of males’s well being and wellness merchandise and providers by way of a safe telemedicine platform. To date, the Company has recognized males’s wellness telemedicine providers and merchandise as a rising sector and particularly associated to the space of erectile dysfunction (ED). The Company has developed a brand new model of ED product below the model identify “Mango” (suppose: “Man, Go!”).For extra data, please go to www.MangoRx.com.Cautionary Note Regarding Forward-Looking StatementsSure statements made on this press launch include forward-looking data inside the which means of relevant securities legal guidelines, together with inside the which means of the Private Securities Litigation Reform Act of 1995 (“forward-looking statements”). These forward-looking statements signify the Company’s present expectations or beliefs regarding future occasions and can typically be recognized utilizing statements that embody phrases equivalent to “estimate,” “expects,” “mission,” “imagine,” “anticipate,” “intend,” “plan,” “foresee,” “forecast,” “doubtless,” “will,” “goal” or related phrases or phrases. These forward-looking statements are topic to dangers, uncertainties and different components, many of that are exterior of the Company’s management which might trigger precise outcomes to differ materially from the outcomes expressed or implied in the forward-looking statements, together with, however not restricted to; our capability to receive further funding and generate revenues to help our operations; dangers related to our ED product which haven’t been, and won’t be, authorized by the U.S. Food and Drug Administration (“FDA”) and haven’t had the profit of the FDA’s scientific trial protocol which seeks to forestall the chance of severe affected person harm and demise; dangers that the FDA could decide that the compounding of our deliberate merchandise doesn’t fall inside the exemption from the Federal Food, Drug, and Cosmetic Act (“FFDCA Act”) offered by Section 503A; dangers related to associated occasion relationships and agreements; the impact of knowledge safety breaches, malicious code and/or hackers; competitors and our capability to create a well known model identify; adjustments in client tastes and preferences; materials adjustments and/or terminations of {our relationships} with key events; vital product returns from clients, product legal responsibility, recollects and litigation related to tainted merchandise or merchandise discovered to trigger well being points; our capability to innovate, broaden our choices and compete in opposition to opponents which can have larger assets; our vital reliance on associated occasion transactions; the projected measurement of the potential marketplace for our applied sciences and merchandise; dangers associated to the undeniable fact that our Chairman and Chief Executive Officer, Jacob D. Cohen and President, Jonathan Arango, mixed have majority voting management over the Company; dangers associated to the vital quantity of shares in the public float, our share quantity, the impact of gross sales of a major quantity of shares in the market, and the undeniable fact that the majority of our shareholders paid much less for his or her shares than the public providing worth of our frequent inventory in our latest preliminary public providing; the undeniable fact that we’ve got a major quantity of excellent warrants to buy shares of frequent inventory at $1.00 per share, the resale of which underlying shares have been registered below the Securities Act of 1933, as amended; our capability to construct and keep our model; cybersecurity, data techniques and fraud dangers and issues with our web sites; adjustments in, and our compliance with, guidelines and laws affecting our operations, gross sales, advertising and/or our merchandise; delivery, manufacturing or manufacturing delays; laws we’re required to adjust to in reference to our operations, manufacturing, labeling and delivery; our dependency on third-parties to prescribe and compound our ED product; our capability to set up or keep relations and/or relationships with third-parties; potential security dangers related to our Mango ED product, together with the use of components, mixture of such components and the dosages thereof; the results of excessive inflation, rising rates of interest and financial downturns, together with potential recessions, in addition to macroeconomic, geopolitical, well being and business developments, pandemics, acts of warfare (together with the ongoing Ukraine/Russian battle) and different large-scale crises; our capability to shield mental property rights; our capability to entice and retain key personnel to handle our enterprise successfully; our capability to keep the itemizing of our frequent inventory on the Nasdaq Capital Market; overhang which can cut back the worth of our frequent inventory; volatility in the buying and selling worth of our frequent inventory; and common client sentiment and financial circumstances which will have an effect on ranges of discretionary buyer purchases of the Company’s merchandise, together with potential recessions and world financial slowdowns. Although we imagine that our plans, intentions and expectations mirrored in or steered by the forward-looking statements we make on this launch are affordable, we offer no assurance that these plans, intentions or expectations can be achieved. Consequently, you shouldn’t take into account any such record to be a whole set of all potential dangers and uncertainties.More data on potential components that might have an effect on the Company’s monetary outcomes is included from time to time in the “Cautionary Note Regarding Forward-Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s filings with the SEC, together with the Company’s Quarterly Report on Form 10-Q for the Quarter ended June 30, 2023. These filings can be found at www.sec.gov and at our web site at https://www.mangoceuticals.com/sec-filings. All subsequent written and oral forward-looking statements attributable to the Company or any individual performing on behalf of the Company are expressly certified of their entirety by the cautionary statements referenced above. Other unknown or unpredictable components additionally might have materials opposed results on the Company’s future outcomes. The forward-looking statements included on this press launch are made solely as of the date hereof. The Company can not assure future outcomes, ranges of exercise, efficiency or achievements. Accordingly, you shouldn’t place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to replace these statements after the date of this launch, besides as required by legislation, and takes no obligation to replace or appropriate data ready by third events that aren’t paid for by the Company. If we replace a number of forward-looking statements, no inference must be drawn that we’ll make further updates with respect to these or different forward-looking statements.Follow Mangoceuticals and MangoRx on social media: https://www.instagram.com/mango.rx https://twitter.com/Mangoceuticals https://www.fb.com/MangoRxOfficialOr simply click on right here to see why Orange is the new Blue: https://www.mangorx.comFOR PUBLIC RELATIONS Lucky Break Public Relations Sahra Simpson [email protected] (323) 602-0091 ext. 704FOR INVESTOR RELATIONS Mangoceuticals Investor Relations Email: [email protected] CONTACT PHOENIX MGMT Marketing & Consulting [email protected]: Mangoceuticals Inc.

https://finance.yahoo.com/information/mangoceuticals-announces-official-launch-mangorx-131500422.html

You May Also Like

About the Author: Amanda